Amgen's cancer drug Kyprolis demonstrated positive results in a study against Takeda's Velcade. Dr. Sean Harper, Amgen, discusses the benefit risk equation for both drugs.» Read More
The second American with Ebola has arrived in Atlanta, reports CNBC's Sue Herera.
Xenex Disinfection Services hopes to fight the war against Ebola. Its CEO Morris Miller shares a demonstration of the company's disinfection robot Sara, which he claims can destroy a deadly virus in 5-10 minutes.
CNBC's Meg Tirrell explains how patients with serious diseases, who have exhausted hope from medicines on the market, turn to compassionate use campaigns.
NBC's Jay Gray reports Ebola patient Nancy Writebol will arrive at Emory Hospital in Atlanta today.
Nathalie Traller, a 15-year-old cancer patient, talks about the challenges of getting access to experimental treatments for a rare form of the disease.
Nathalie Traller has a rare cancer, but at 15 years old, it's been difficult to get access to treatments.
CNBC's Bertha Coombs reports a patient with a high fever and gastrointestinal symptoms is undergoing screenings to determine cause of symptoms at Mt. Sinai hospital.
Ebola is now in 4 countries. NBC News' Sarah Daloff reports Emory Hospital in Atlanta, Georgia, is preparing for the arrival of the second Ebola patient Nancy Writebol.
Lawrence Livermore is reaching out to private industry amid a race for talent and ideas to solve pressing issues including national security.
Reports say there could have been 100 AIDS researchers and advocates on the Malaysia Airlines flight which was shot down in Ukraine, with CNBC's Meg Tirrell.
Neuroscientist Read Montague performed a study of traders' brain activity while trading. He shares which traders made the most money in the experiment.
Climate change skeptic group The Heartland Institute hosts its annual conference this week and hopes to take on President Obama and others.
CNBC's Meg Tirrell reports which pharmaceutical stocks are ready for the future of medicine, including Covidien's swallowable pill-size camera.
Why does the U.S. spend so much money on health care? Daniel Kraft, Exponential Medicine executive director, says the U.S. spends a lot of money on "sick" care, not health care, and provides insight to new technology developments in the industry.
This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.
The big topic at this year's cancer care conference ASCO will be immunotherapy drugs. CNBC's Meg Tirrell explains how these drugs work.
CNBC's Meg Tirrell reports the Center for Disease Control has confirmed the second case of MERS has been identified in the U.S.
Lawmakers in four states are considering changing the rules to allow terminally ill people access to experimental drugs before they have FDA approval. Kenneth Goodman, University of Miami, thinks this would be a bad bet for patients. Miles Nadal, MDC Partners Chairman & CEO, weighs in.
CNBC's Meg Tirrell spoke with Merck Chairman & CEO Ken Frazier about the company's decision to sell its over the counter health care products to Bayer.
CNBC's Meg Tirrell reports the World Health Organization has confirmed about 262 cases of the MERS virus, of which 93 people have died. Dr. William Schaffner of the Vanderbilt School of Medicine, provides insight.